RE:Reverse engineering the share price.FY2019 KNR had 15M in revenue and I’d argue they were on track for 20-25M in fiscal 2020 taking the New Found Air acquisition into account that added 3.7M of additional annual revenue... had there been no pandemic and taking the incremental acquisition into account in 2020.
This was way undervalued and under the radar pre-BioCloud. That is no longer the case now as KNR is on a lot more and never or radars now. I’d expect revenues to expand considerably post pandemic in the core business also to make up the delayed project revenue and pent up demand.
I’d personally value the core business at minimum $2 assuming $20-25M in forward revenue.
Now take into consideration my opinion that USSC would not sign up for 5K units annually for the exclusive distribution if they didn’t think that was an easily achievable target, let alone the other distributors, direct sales and everything else going on we have no visibility to... $3.40 is a steal.